The global hip replacement implants market size was estimated at USD 4.37 billion in 2025 and is anticipated to grow from USD 4.45 billion in 2026 till USD 5.36 billion in 2034, growing at a CAGR of 2.35% from 2026-2034.
Download a Free Sample to Explore Detailed Market Insights
Source: Straits Research Analysis
The hip replacement implants market is witnessing a clear trend from the conventional metal on polyethylene bearing towards advanced ceramic on polyethylene combinations, which presents as a significant market trend, as it provides superior wear resistance, reduced risk of loosening, and longer durability.
Such a factor highlights the growing adoption of materials that enhance patient outcomes and extend implant lifespan.
Transition from conventional open surgeries to robotic-assisted minimally invasive procedures presents as a significant market trend as it performs procedures via smaller incisions and also improves surgical precision while reducing recovery times.
The rising number of hip replacement procedures per 100,000 population is a key driver for the growth of the market.
The graph below depicts the number of hip replacement procedures from 2023 to 2024.
Source: The Organisation for Economic Co-operation and Development and Straits Analysis
Such factor reflects the growing prevalence of surgeries for the hip replacement, which fuels demand for advanced implants.
The rise of bundled payment reimbursement models is driving the growth of the market by promoting cost-efficient, and high-quality care.
Such factor links financial accountability to patient outcomes across the entire care continuum, while encouraging the use of advanced, as well as durable hip implants.
Product recalls have impacted the market, leading to potential delays in surgeries and increased healthcare costs.
Such factors highlight the critical importance of stringent quality control and regulatory compliance, as these lapses directly affect patient safety, surgical outcomes, and trust in healthcare providers, while also posing operational and financial challenges for manufacturers.
The development and adoption of personalized hip replacement implants presents as a significant market opportunity as it enables the creation of implants tailored to an individual’s unique anatomy.
Such a factor allows manufacturers to cater the specific needs of patients, leading to improved surgical outcomes and patient satisfaction, thereby capitalizing on this emerging market opportunity.
Download Free Sample Reportto Get Detailed Insights.
The total hip replacement implants segment dominated the market with a revenue share of 39.60% in 2025. The growth is attributed to rising osteoarthritis prevalence, advanced implant designs, and minimally invasive surgical adoption.
The ceramic on polyethylene segment is anticipated to grow at a CAGR of 3.32% during 2026 - 2034. This growth is attributed to the longer implant lifespan and reduced risk of osteolysis.
The hospitals & surgery centers segment dominated the market in 2025. This growth is attributed to the availability of advanced surgical infrastructure, skilled orthopedic specialists, and higher patient inflow.
The North America region dominated the market with a revenue share of 52.16% in 2025. The growth is attributed to factors such as high prevalence of osteoarthritis and hip fractures, advanced healthcare infrastructure, widespread adoption of technologically advanced implants and robotic-assisted surgeries.
The Asia Pacific region is the fastest-growing region with a CAGR of 4.35% during the forecast timeframe. The growth is attributed to factors such as a growing aging population, rising government initiatives to improve healthcare access and the expansion of leading global implant manufacturers establishing a stronger presence across the region.
The global hip replacement implants market is highly fragmented in nature due to the presence of numerous manufacturers competing across regions, ranging from large multinational companies to smaller local players. This fragmentation is driven by diverse product offerings, varying implant technologies (such as ceramic on polyethylene, metal on polyethylene, and 3D printed implants), as well as the need to cater to specific patient demographics and surgical preferences.
The industry participants are inclined towards innovation in implant materials and designs, adoption of robotic-assisted and minimally invasive surgical technologies, strategic collaborations with research institutions, and expansion into emerging markets to enhance patient outcomes.
MatOrtho Limited is an emerging player in the market, is an orthopaedic medical device manufacturer that specializes in designing and producing advanced joint replacement devices.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com